.Welcome to today's Chutes & Ladders, our roundup of notable leadership hirings, shootings and al...
.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...
.AbbVie has actually come back to the resource of its antipsychotic goliath Vraylar in search of one...
.GenSight Biologics is actually full weeks far from losing loan. Once again. The biotech simply has ...
.Monopar Therapeutics is actually recuperating a medicine from the scrap heap of AstraZeneca's uncom...
.With brand-new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of anal...
.After developing a genetics treatment collaboration with Dyno Therapeutics in 2020, Roche is actual...
.Lundbeck is actually slashing the book market value of its $250 thousand Abide Therapies acquistion...
.The assimilation of real-world data (RWD) in to procedure feasibility and also site assortment has ...
.At this year's Strong Biotech Peak in Boston, our company caught up with forerunners in the biotech...